544 related articles for article (PubMed ID: 16640001)
1. Leptin changes in Taiwanese girls with central precocious puberty before and during the GnRH agonist treatment.
Su PH; Wang SL; Lin CY; Chen JY; Changlai CP; Jian SH; Chen SJ
Acta Paediatr Taiwan; 2005; 46(5):278-83. PubMed ID: 16640001
[TBL] [Abstract][Full Text] [Related]
2. Serum leptin levels in girls with precocious puberty.
Verrotti A; Basciani F; Trotta D; De Simone M; Morgese G; Chiarelli F
Diabetes Nutr Metab; 2003 Apr; 16(2):125-9. PubMed ID: 12846452
[TBL] [Abstract][Full Text] [Related]
3. Serum leptin levels in patients with progressive central precocious puberty.
Heger S; Partsch CJ; Peter M; Blum WF; Kiess W; Sippell WG
Pediatr Res; 1999 Jul; 46(1):71-5. PubMed ID: 10400137
[TBL] [Abstract][Full Text] [Related]
4. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
Massart F; Federico G; Harrell JC; Saggese G
Neuroendocrinology; 2009; 90(3):307-14. PubMed ID: 19641297
[TBL] [Abstract][Full Text] [Related]
5. Adequacy of a single unstimulated luteinizing hormone level to diagnose central precocious puberty in girls.
Houk CP; Kunselman AR; Lee PA
Pediatrics; 2009 Jun; 123(6):e1059-63. PubMed ID: 19482738
[TBL] [Abstract][Full Text] [Related]
6. Basal luteinizing hormone/follicle stimulating hormone ratio in diagnosis of central precocious puberty.
Supornsilchai V; Hiranrat P; Wacharasindhu S; Srivuthana S; Aroonparkmongkol S
J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S145-51. PubMed ID: 12929982
[TBL] [Abstract][Full Text] [Related]
7. Changes in body mass index during gonadotropin-releasing hormone agonist treatment for central precocious puberty and early puberty.
Lee HS; Yoon JS; Roh JK; Hwang JS
Endocrine; 2016 Nov; 54(2):497-503. PubMed ID: 27444748
[TBL] [Abstract][Full Text] [Related]
8. Leptin and estradiol as related to change in pubertal status and body weight.
Larmore KA; O'Connor D; Sherman TI; Funanage VL; Hassink SG; Klein KO
Med Sci Monit; 2002 Mar; 8(3):CR206-10. PubMed ID: 11889458
[TBL] [Abstract][Full Text] [Related]
9. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
Léger J; Reynaud R; Czernichow P
J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
[TBL] [Abstract][Full Text] [Related]
10. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.
Clemons RD; Kappy MS; Stuart TE; Perelman AH; Hoekstra FT
Am J Dis Child; 1993 Jun; 147(6):653-7. PubMed ID: 8506834
[TBL] [Abstract][Full Text] [Related]
11. Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg).
Carel JC; Lahlou N; Jaramillo O; Montauban V; Teinturier C; Colle M; Lucas C; Chaussain JL
J Clin Endocrinol Metab; 2002 Sep; 87(9):4111-6. PubMed ID: 12213857
[TBL] [Abstract][Full Text] [Related]
12. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
Chen SK; Fan X; Tang Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):374-6. PubMed ID: 19470261
[TBL] [Abstract][Full Text] [Related]
13. The histrelin implant: a novel treatment for central precocious puberty.
Hirsch HJ; Gillis D; Strich D; Chertin B; Farkas A; Lindenberg T; Gelber H; Spitz IM
Pediatrics; 2005 Dec; 116(6):e798-802. PubMed ID: 16322137
[TBL] [Abstract][Full Text] [Related]
14. Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty.
Kappy M; Stuart T; Perelman A; Clemons R
J Clin Endocrinol Metab; 1989 Nov; 69(5):1087-9. PubMed ID: 2507570
[TBL] [Abstract][Full Text] [Related]
15. Initial growth deceleration during GnRH analogue therapy for precocious puberty.
Mouat F; Hofman PL; Jefferies C; Gunn AJ; Cutfield WS
Clin Endocrinol (Oxf); 2009 May; 70(5):751-6. PubMed ID: 19178517
[TBL] [Abstract][Full Text] [Related]
16. [Study on cases of precocious puberty].
Nanbu A; Kumamoto Y; Takagi Y; Maruta H
Hinyokika Kiyo; 1989 Oct; 35(10):1715-20. PubMed ID: 2532862
[TBL] [Abstract][Full Text] [Related]
17. Central precocious puberty: clinical and laboratory features.
Chemaitilly W; Trivin C; Adan L; Gall V; Sainte-Rose C; Brauner R
Clin Endocrinol (Oxf); 2001 Mar; 54(3):289-94. PubMed ID: 11298079
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty.
Lee PA; Klein K; Mauras N; Neely EK; Bloch CA; Larsen L; Mattia-Goldberg C; Chwalisz K
J Clin Endocrinol Metab; 2012 May; 97(5):1572-80. PubMed ID: 22344198
[TBL] [Abstract][Full Text] [Related]
19. Serum Anti-Müllerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment.
Nam HK; Kim HR; Rhie YJ; Lee KH
J Korean Med Sci; 2017 Mar; 32(3):475-479. PubMed ID: 28145651
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral content in girls with precocious puberty treated with gonadotropin-releasing hormone analog.
Verrotti A; Chiarelli F; Montanaro AF; Morgese G
Gynecol Endocrinol; 1995 Dec; 9(4):277-81. PubMed ID: 8629454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
